MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,331,000 | -9.4% | 248,090 | +5.2% | 0.35% | -12.9% |
| Q4 2017 | $8,096,000 | -27.4% | 235,735 | -23.5% | 0.40% | -38.4% |
| Q3 2017 | $11,146,000 | +29.2% | 308,063 | -7.7% | 0.65% | +13.2% |
| Q2 2017 | $8,625,000 | -12.9% | 333,779 | -35.3% | 0.58% | -9.3% |
| Q1 2017 | $9,906,000 | +47.7% | 515,921 | +28.2% | 0.64% | +26.4% |
| Q4 2016 | $6,709,000 | +21.7% | 402,435 | +50.3% | 0.50% | +23.9% |
| Q3 2016 | $5,511,000 | +99.0% | 267,771 | +195.9% | 0.41% | +72.0% |
| Q2 2016 | $2,770,000 | -87.3% | 90,508 | -84.5% | 0.24% | -87.9% |
| Q1 2016 | $21,867,000 | -22.3% | 584,204 | -10.4% | 1.94% | -26.7% |
| Q4 2015 | $28,153,000 | +0.4% | 652,288 | -12.8% | 2.65% | -4.4% |
| Q3 2015 | $28,030,000 | +6.0% | 747,861 | -3.9% | 2.77% | +34.8% |
| Q2 2015 | $26,439,000 | +40.4% | 777,833 | +46.2% | 2.06% | +35.9% |
| Q1 2015 | $18,830,000 | – | 531,933 | – | 1.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |